Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)

Clinical trial NCT01093794 · COMPLETED

Trial details

NCT number: NCT01093794
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2010-04-01
Primary completion: 2010-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.